| Valuation method | Value, CHF | Upside, % |
|---|---|---|
| Artificial intelligence (AI) | 84.71 | -46 |
| Intrinsic value (DCF) | 48.47 | -69 |
| Graham-Dodd Method | n/a | |
| Graham Formula | 8.22 | -95 |
Dätwyler Holding AG is a leading Swiss manufacturer of high-precision elastomer components, serving critical industries such as healthcare, mobility, oil and gas, and food and beverage. Founded in 1915 and headquartered in Altdorf, Switzerland, the company operates through two key segments: Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment specializes in rubber components for medical devices, including prefilled syringes, blood collection systems, and IV administration sets, catering to stringent regulatory requirements. The Industrial Solutions segment provides advanced elastomer solutions for electromobility, brake systems, fuel management, and sealing applications across various industrial sectors. With a global footprint spanning Europe, North America, South America, and Asia, Dätwyler leverages its expertise in elastomer technology to deliver high-performance, customized solutions. The company’s commitment to innovation and quality positions it as a trusted partner in industries where precision and reliability are paramount. As a subsidiary of Pema Holding AG, Dätwyler continues to expand its market presence, driven by growing demand in healthcare and industrial applications.
Dätwyler Holding AG presents a mixed investment profile with both attractive growth opportunities and notable risks. The company’s strong positioning in the healthcare and industrial elastomer markets, particularly in high-growth areas like electromobility and medical devices, offers significant upside potential. However, its relatively high beta of 1.235 indicates above-average volatility, which may deter risk-averse investors. The company’s revenue of CHF 1.1 billion and net income of CHF 31.1 million reflect steady performance, though margins could be pressured by rising input costs and competitive pressures. Dätwyler’s dividend yield, supported by a CHF 3.2 per share payout, adds appeal for income-focused investors. Nonetheless, its total debt of CHF 574.4 million against cash reserves of CHF 127.2 million warrants caution, as leverage could constrain financial flexibility. Investors should weigh Dätwyler’s niche expertise and global reach against sector cyclicality and operational risks.
Dätwyler Holding AG competes in the specialized elastomer components market, where its competitive advantage stems from deep technical expertise, a diversified customer base, and a strong focus on high-value applications. The company’s Healthcare Solutions segment benefits from stringent regulatory barriers and long-term customer relationships, which provide stability and pricing power. In contrast, the Industrial Solutions segment faces more intense competition, particularly in commoditized product lines. Dätwyler’s ability to innovate and customize solutions for niche applications, such as electromobility and medical devices, differentiates it from broader industrial suppliers. However, the company’s reliance on elastomer materials exposes it to raw material price volatility, which can erode margins. Competitors with greater scale or vertical integration may have cost advantages in standardized products. Dätwyler’s global manufacturing footprint enhances its responsiveness to regional demand but also introduces operational complexity. The company’s mid-sized scale limits its bargaining power with large customers compared to industry giants, though its focus on high-margin, technically demanding products helps mitigate this disadvantage. Overall, Dätwyler’s competitive positioning is strongest in healthcare and specialized industrial markets, where its technical capabilities and customer intimacy outweigh scale disadvantages.